Comments to FDA: PDUFA Share page: Docket Number: FDA-2010-N-0128 CHPA comments on proposed recommendations for the reauthorization of the Prescription Drug User Fee Act. Download Document Issues: OTC Medicines Monograph Reform Rx-to-OTC Switch User Fees Related Posts Press Releases and Statements CHPA Response to Study Examining Prescription Acid Reflux Drugs Apr 25, 2024 Articles Polibrief: Consumer Data Privacy: State Efforts to Preserve Privacy Apr 16, 2024 Press Releases and Statements Self-Care Industry Representatives Participate in Capitol Hill Briefing Highlighting Legislative Priorities Apr 11, 2024